Abstract
The prevention and treatment of lifestyle disease involves overlapping factors. Those at the highest risk for the development of lifestyle disease are also at the highest risk for poor treatment outcomes. Although behavioral treatment of lifestyle disease has demonstrated efficacy on average, considerable individual variation exists in treatment response. In clinical settings, individuals unresponsive to treatment are typically provided escalated care. Community-based care is designed to reach high-risk populations unlikely to seek medical care. However, in community settings escalated treatment options are not usually available for individuals unresponsive to treatment. Addressing this gap is imperative to improve health outcomes of high-risk populations and to identify individuals who may be resistant to behavioral lifestyle treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 354-358 |
| Number of pages | 5 |
| Journal | American Journal of Lifestyle Medicine |
| Volume | 13 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 1 2019 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 The Author(s).
Keywords
- behavioral treatment
- community-based
- individual
- resistance
- response